Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
Isfahan University of Medical Sciences · Ford Motor Company (United States) · +4 more institutions
Abstract
Previous global analyses, with known underdiagnosis and single cause per death attribution systems, provide only a small insight into the suspected high population health effect of sickle cell disease. Completed as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, this study delivers a comprehensive global assessment of prevalence of sickle cell disease and mortality burden by age and sex for 204 countries and territories from 2000 to 2021.
We estimated cause-specific sickle cell disease mortality using standardised GBD approaches, in which each death is assigned to a single underlying cause, to estimate mortality rates from the International Classification of Diseases (ICD)-coded vital registration, surveillance, and verbal autopsy data. In parallel, our goal was to estimate a more accurate account of sickle cell disease health burden using four types of epidemiological data on sickle cell disease: birth incidence, age-specific prevalence, with-condition mortality (total deaths), and excess mortality (excess deaths). Systematic reviews, supplemented with ICD-coded hospital discharge and insurance claims data, informed this modelling approach. We employed DisMod-MR 2.1 to triangulate between these measures-borrowing strength from predictive covariates and across age, time, and geography-and generated internally consistent estimates of incidence, prevalence, and mortality for three distinct genotypes of sickle cell disease: homozygous sickle cell disease and severe sickle cell β-thalassaemia, sickle-haemoglobin C disease, and mild sickle cell β-thalassaemia. Summing the three models yielded final estimates of incidence at birth, prevalence by age and sex, and total sickle cell disease mortality, the latter of which was compared directly against cause-specific mortality estimates to evaluate differences in mortality burden assessment and implications for the Sustainable Development Goals (SDGs).
Citation impact
- FWCI
- 173.57
- Percentile
- 100%
- References
- 81
Authors
153- ATAzalea ThomsonCorresponding
Isfahan University of Medical Sciences, Ford Motor Company (United States), Jimma University, University of Washington, University of Health and Allied Sciences, Institute for Health Metrics and Evaluation
- TATheresa A. McHugh
Isfahan University of Medical Sciences, Ford Motor Company (United States), Jimma University, University of Washington, University of Health and Allied Sciences, Institute for Health Metrics and Evaluation
- APAssaf P. Oron
Isfahan University of Medical Sciences, Ford Motor Company (United States), Jimma University, University of Washington, University of Health and Allied Sciences, Institute for Health Metrics and Evaluation
- CTCorey Teply
Isfahan University of Medical Sciences, Ford Motor Company (United States), Jimma University, University of Washington, University of Health and Allied Sciences, Institute for Health Metrics and Evaluation
- NLNikhil Lonberg
Isfahan University of Medical Sciences, Ford Motor Company (United States), Jimma University, University of Washington, University of Health and Allied Sciences, Institute for Health Metrics and Evaluation
Topics & keywords
- Medicine
- Disease
- Epidemiology
- Population
- Incidence (geometry)
- Disease burden
- Mortality rate
- Pediatrics
Funding
- BABill and Melinda Gates Foundation
- YUYale University
- CCCleveland Clinic
- CCCleveland Clinic Foundation
- FIFlorida International University
- TUTulane University
- IUIran University of Medical Sciences
- SESouth Eastern Sydney Local Health District
- UOUniversity of Central Punjab
- HPHøgskulen på Vestlandet
- TĐTrường Đại học Duy Tân
- MAManipal Academy of Higher Education
- CUChandigarh University
- KMKasturba Medical College, Manipal
- PUPhiladelphia University
- YUYork University
- UOUniversity of Warwick
- ICImperial College London
- UOUniversity of Aberdeen
- DODepartment of Sport and Recreation, Government of Western Australia
- MUMacquarie University
- UOUniversity of Pretoria
- ICIndian Council of Medical Research
- UGUniversity Grants Commission
- SCSouthern Cross University
- UOUniversity of New South Wales
- UOUniversity of Sydney
- UOUniversity of Technology Sydney
- AOAcademy of Scientific Research and Technology
- ASAin Shams University
- BHBanaras Hindu University
- SAScience and Technology Development Fund
- MDMinistero della SaluteAward: 34/2017
- UOUniversity of Toronto
- MOMinistry of Health and Medical Education
- IUIsfahan University of Medical Sciences
- KIKarolinska Institutet
- KAKing Abdulaziz University
- SUShiraz University of Medical Sciences
- SQSultan Qaboos University
- TUTehran University of Medical Sciences and Health Services
- KAKing Abdulaziz City for Science and Technology
- AJAhvaz Jundishapur University of Medical Sciences
- UIUniversitetet i Bergen
- SUShiraz University
- UDUniversidade de São Paulo
- UŁUniwersytet Łódzki
- UOUniversity of Jordan
- BUBabol University of Medical Sciences
- UNUniversidad Nacional Autónoma de México
- SBShahid Beheshti University of Medical Sciences
- SNSecretaría Nacional de Ciencia, Tecnología e Innovación
- SUShaqra University
- JIJawaharlal Institute Of Postgraduate Medical Education and Research
- UAUniversidad Autónoma de Sinaloa
- AUAlfaisal University
- MRMedical Research Council
- NHNational Health and Medical Research Council
- WMWarwick Medical School
- SNSistema Nacional de Investigadores